Invention Grant
- Patent Title: Heterobicyclic carboxamides as inhibitors for kinases
- Patent Title (中): 异环碳酰胺作为激酶抑制剂
-
Application No.: US13613034Application Date: 2012-09-13
-
Publication No.: US08486954B2Publication Date: 2013-07-16
- Inventor: Gerald David Artman, III , Jason Matthew Elliott , Nan Ji , Donglei Liu , Fupeng Ma , Nello Mainolfi , Erik Meredith , Karl Miranda , James J. Powers , Chang Rao
- Applicant: Gerald David Artman, III , Jason Matthew Elliott , Nan Ji , Donglei Liu , Fupeng Ma , Nello Mainolfi , Erik Meredith , Karl Miranda , James J. Powers , Chang Rao
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Joshua Roth
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D487/08 ; A61K31/404 ; A61P27/02
Abstract:
The invention relates to novel organic compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula I and to the use of a compound of formula I for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in the treatment of tumor diseases and ocular neovascular diseases.
Public/Granted literature
- US20130005751A1 HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES Public/Granted day:2013-01-03
Information query
